One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent in Patients With Diabetes Mellitus * Response

Circulation - United States
doi 10.1161/01.cir.0000142207.05425.76
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

One-Year Clinical Outcomes of Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stent System in Patients With Coronary Artery Disease

World Journal of Cardiovascular Diseases
2017English

Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- And Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Damage to Polymer of Paclitaxel-Eluting Stent

Circulation Journal
MedicineCardiovascular MedicineCardiology
2008English

Vascular Responses in Patients With and Without Diabetes Mellitus After Everolimus-Eluting Stent Implantation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Gender-Based Outcomes Among Patients With Diabetes Mellitus After Percutaneous Coronary Intervention in the Drug-Eluting Stent Era

International Heart Journal
MedicineCardiovascular MedicineCardiology
2011English

Safety and Efficacy of Biodegradable Polymer-Coated Thin Strut Sirolimus-Eluting Stent vs. Durable Polymer-Coated Everolimus-Eluting Stent in Patients With Acute Myocardial Infarction

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2018English

One-Year Clinical Outcomes of Patients With Versus Without Acute Coronary Syndrome With 3-Month Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Stent Implantation

PLoS ONE
Multidisciplinary
2020English

Controlled Release of Paclitaxel From Biodegradable Polymer Films for Drug-Eluting Stents

Polymer (Korea)
PolymersMaterials ChemistryPlasticsChemical Engineering
2010English

Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients: The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy